Hermetica Superfood Encyclopedia
The Short Answer
Maytenus undata contains triterpenoids, flavonoids, and tannins that modulate inflammatory pathways and inhibit cyclooxygenase-related enzyme activity to produce analgesic and anti-inflammatory effects. Ethnopharmacological documentation from Kenyan highland communities identifies its bark and leaf preparations as primary treatments for musculoskeletal pain, though formal clinical quantification of effect magnitude remains limited to preclinical and in vitro models.
CategoryHerb
GroupAfrican
Evidence LevelPreliminary
Primary KeywordMaytenus undata benefits
Maytenus — botanical close-up
Health Benefits
**Analgesic and Pain Relief**
Bark and leaf decoctions used by Kenyan highland communities for musculoskeletal and arthritic pain, with triterpenoids such as friedelane-type compounds implicated in inhibiting pro-inflammatory mediator release.
**Anti-inflammatory Activity**
Extracts from related Maytenus species demonstrate suppression of TNF-α, IL-6, and prostaglandin E2 synthesis in vitro, consistent with the genus-wide terpenoid and flavonoid chemistry shared by M. undata.
**Antioxidant Protection**
Flavonoids including catechin and quercetin derivatives contribute to free radical scavenging, reducing oxidative stress markers in hepatic tissue models comparable to findings in M. ilicifolia.
**Gastrointestinal Support**
Traditional use in highland Africa includes treatment of gastric pain and ulcers, with tannins and phenolic compounds likely contributing mucosal protective effects through astringent and anti-secretory mechanisms.
**Antimicrobial Properties**
Alkaloid and tannin fractions from Maytenus genus members exhibit inhibitory activity against Gram-positive bacteria and dermatophytes in disc diffusion assays, supporting traditional wound and infection applications.
**Wound Healing**
Poultice preparations from leaves are applied topically by traditional healers in East Africa to accelerate wound closure, with tannin-mediated protein precipitation supporting tissue astringency and local hemostasis.
Origin & History
Natural habitat
Maytenus undata, commonly called the mountain khat or highveld maytenus, is native to the Afromontane forests and highland grasslands of East and southern Africa, particularly Kenya, Ethiopia, Tanzania, and South Africa, where it grows at elevations between 1,500 and 3,000 meters. It thrives in montane forest margins, rocky hillsides, and moist highland environments, often appearing as a shrub or small tree. The plant has been harvested primarily from wild populations by highland communities, particularly in Kenyan highland regions, with limited commercial cultivation documented.
“Maytenus undata holds significant ethnomedicinal importance among Bantu-speaking highland communities in Kenya, Ethiopia, and Tanzania, where it is integrated into traditional healing systems as a primary analgesic and anti-inflammatory remedy for arthritis, rheumatic pain, and musculoskeletal injuries sustained during agricultural labor at altitude. Healers in the Kenyan highlands, including communities in the Aberdare Range and Mount Kenya region, historically harvest the bark with careful sustainable protocols to avoid killing the tree, reflecting indigenous conservation knowledge. The genus Maytenus more broadly has deep traditional use across Africa and South America, with African species documented in ethnobotanical compendia from the 19th and 20th centuries by colonial-era botanists including collections held in East African herbaria. In southern African traditional medicine, related Maytenus species are known as 'umayime' or 'kransaasboom' and carry cultural significance as protective and healing plants administered during rites of passage and illness recovery ceremonies.”Traditional Medicine
Scientific Research
The scientific evidence base for Maytenus undata specifically is limited predominantly to ethnopharmacological surveys and botanical documentation rather than controlled experimental studies, with most mechanistic research conducted on the closely related South American species M. ilicifolia and the broader Maytenus genus. In vitro studies on Maytenus genus extracts demonstrate antioxidant, anti-inflammatory, and enzyme-inhibitory properties using LDL oxidation assays, DPPH radical scavenging, and α-amylase inhibition models, but these have not been translated into human clinical trials with defined sample sizes or effect measures. Ethnobotanical surveys in Kenya and Ethiopia document M. undata as a regionally significant analgesic plant among highland communities, providing qualitative validation of traditional use without quantitative efficacy data. No randomized controlled trials, systematic reviews, or meta-analyses specific to M. undata were identified in the available literature, placing the current evidence firmly in the preclinical and traditional-use category.
Preparation & Dosage
Traditional preparation
**Traditional Bark Decoction**
10–20 g of dried bark boiled in 500 mL water for 15–20 minutes, consumed as 1–2 cups daily for pain relief, as documented in Kenyan highland ethnobotanical surveys
Approximately .
**Leaf Infusion (Tea)**
Dried leaves steeped in hot water, used for gastrointestinal complaints and mild fever; no standardized dose established.
**Topical Poultice**
Fresh or rehydrated crushed leaves applied directly to painful joints or wounds in traditional wound-care practice.
**Ethanolic Extract (Research Grade)**
Experimental preparations using 70–96% ethanol have been used in laboratory studies; no commercial standardized extract with defined triterpenoid or flavonoid percentages is currently available.
**Standardization**
No commercial standardization percentage has been established for M. undata; related M. ilicifolia supplements are sometimes standardized to polyphenol content, but this has not been applied to M. undata.
**Timing**
Traditional use is typically acute to subacute, taken as needed for pain episodes rather than as a daily supplement regimen.
Nutritional Profile
Maytenus undata is not consumed as a dietary staple and lacks a conventional macronutrient or micronutrient profile relevant to nutrition science. Phytochemically, the leaves and bark are rich in polyphenols, with flavonoids (quercetin, kaempferol, catechin derivatives) and condensed tannins representing the primary phenolic classes; quantitative concentrations have not been published specifically for M. undata but are estimated in related species at 2–8% total phenolics by dry weight. Triterpenoids of the friedelane and oleanane types are concentrated in bark resin fractions, and alkaloid content, while present genus-wide, is quantitatively low. Bioavailability of the major flavonoid and triterpenoid constituents is expected to be moderate and influenced by food matrix interactions, preparation method (aqueous vs. ethanolic extraction favoring different compound classes), and gut microbiome-mediated phase II transformations.
How It Works
Mechanism of Action
The primary analgesic mechanism attributed to Maytenus undata and related species involves triterpenoids of the friedelane, lupane, and oleanane skeletal types, which have been shown in the broader Maytenus genus to inhibit nuclear factor-kappa B (NF-κB) activation and downstream prostaglandin synthesis, reducing peripheral sensitization of nociceptors. Flavonoids such as quercetin and kaempferol derivatives inhibit cyclooxygenase-2 (COX-2) enzymatic activity and scavenge reactive oxygen species through electron donation, attenuating oxidative amplification of inflammatory pain signals. Tannins and phenolic acids contribute astringent and anti-secretory activity by precipitating mucosal proteins and reducing histamine-mediated vascular permeability. Alkaloid fractions present across the Maytenus genus may further modulate central pain processing by interacting with opioid-adjacent receptor pathways, though this mechanism has not been characterized specifically for M. undata.
Clinical Evidence
No formal clinical trials have been conducted on Maytenus undata as of the current evidence review, and the clinical evidence base is derived entirely from ethnopharmacological field surveys and extrapolation from preclinical studies on taxonomically related Maytenus species. Ethnopharmacological documentation from Kenyan and East African highland communities consistently identifies M. undata bark and leaf preparations as treatments for pain, fever, and gastrointestinal complaints, lending qualitative cross-cultural validity to the traditional indication. In vitro studies on genus-level extracts demonstrate measurable inhibition of pro-inflammatory enzymes and oxidative stress markers, but without pharmacokinetic data, bioavailability estimates, or human dose-response curves, translation to clinical recommendations is not supported. Confidence in efficacy claims must therefore remain low until prospective human studies are conducted.
Safety & Interactions
Safety data specific to Maytenus undata are absent from the peer-reviewed literature, and risk characterization must rely on the broader Maytenus genus toxicology profile and general principles of tannin- and alkaloid-containing plant safety. At traditionally used doses, aqueous bark decoctions are generally considered low-risk by practicing healers, though prolonged or high-dose use of tannin-rich preparations may contribute to gastrointestinal irritation, constipation, or reduced iron absorption due to tannin-mineral chelation. Maytansinoid compounds identified in the Maytenus genus are potent cytotoxic agents at pharmacological doses and have been developed as anticancer warheads; their presence at trace levels in whole plant material warrants caution with high-dose or concentrated extract use, and cytotoxic risk at therapeutic traditional doses remains uncharacterized. Potential interactions with hepatically metabolized drugs, anticoagulants, and anti-inflammatory medications (NSAIDs) are plausible given the COX-modulatory activity of flavonoid fractions, and use during pregnancy and lactation should be avoided in the absence of reproductive safety data.
Synergy Stack
Hermetica Formulation Heuristic
Also Known As
Maytenus undataMountain khatHighveld maytenusCelastrus undatusGymnosporia undata
Frequently Asked Questions
What is Maytenus undata used for traditionally?
Maytenus undata is used primarily as a pain-relieving and anti-inflammatory remedy by highland communities in Kenya, Ethiopia, and Tanzania, with bark decoctions applied to musculoskeletal pain, arthritis, and rheumatic conditions. It is also used for gastrointestinal complaints including gastric pain and ulcers, and leaf poultices are applied topically to wounds and inflamed joints in traditional healing practice.
What are the active compounds in Maytenus undata?
Maytenus undata shares the phytochemical profile characteristic of the Maytenus genus, including triterpenoids of the friedelane, lupane, and oleanane types, flavonoids such as quercetin and kaempferol derivatives, condensed tannins, alkaloids, and phenolic acids. Maytansinoid compounds, known for potent cytotoxic activity, are also present across the genus, though their concentration in M. undata specifically has not been fully quantified.
Is there clinical trial evidence supporting Maytenus undata for pain?
No randomized controlled trials or formal clinical studies have been conducted specifically on Maytenus undata for pain or any other indication as of the current literature review. Evidence is limited to ethnopharmacological surveys documenting traditional use in East African highlands and in vitro studies on related Maytenus species demonstrating anti-inflammatory enzyme inhibition, which have not been replicated in human trials.
Is Maytenus undata safe to use, and are there drug interactions?
Formal safety and toxicology data for Maytenus undata are not available in the peer-reviewed literature, but at traditional aqueous decoction doses, it is generally regarded as low-risk within its traditional cultural context. High-dose or concentrated extract use may pose risks due to cytotoxic maytansinoid compounds and tannin-related gastrointestinal effects, and potential interactions with NSAIDs, anticoagulants, and hepatically metabolized drugs cannot be excluded based on known flavonoid pharmacology.
How is Maytenus undata prepared and what dose is used?
The most documented traditional preparation is a bark decoction made by boiling approximately 10–20 grams of dried bark in 500 mL of water for 15–20 minutes, with one to two cups consumed daily for pain management as practiced in Kenyan highland communities. No standardized commercial extract or clinically validated dose range has been established, and preparation methods vary across communities, with leaf infusions and topical poultices also in common use.
What is the difference between Maytenus undata bark and leaf preparations in terms of effectiveness?
Both Maytenus undata bark and leaves are used traditionally, but the bark decoctions are more commonly documented in ethnobotanical literature for pain relief among Kenyan highland communities. Leaf preparations may contain similar active compounds including friedelane-type triterpenoids, but comparative studies directly evaluating bark versus leaf efficacy are limited. The choice between forms often depends on availability and traditional preparation methods within specific regions.
Who should consider using Maytenus undata for pain management, and who should avoid it?
Individuals experiencing musculoskeletal or arthritic pain may benefit from Maytenus undata, particularly those seeking traditional herbal alternatives with anti-inflammatory properties. However, pregnant and nursing women should avoid this ingredient due to insufficient safety data, and individuals with bleeding disorders or taking anticoagulants should exercise caution given potential interactions with inflammatory pathways. Those with sensitivity to plants in the Celastraceae family should also consult a healthcare provider before use.
How does the anti-inflammatory mechanism of Maytenus undata compare to conventional pain relievers?
Maytenus undata works by suppressing pro-inflammatory mediators like TNF-α, IL-6, and prostaglandin E2 synthesis, a mechanism partly overlapping with NSAIDs which also inhibit prostaglandin production. However, Maytenus undata may offer a broader modulation of inflammatory cytokines through its friedelane-type triterpenoid compounds, though this multi-target approach has not yet been directly compared to standard pain medications in clinical trials. The herbal preparation likely produces a slower onset but potentially longer-lasting effect compared to synthetic analgesics.
Explore the Full Encyclopedia
7,400+ ingredients researched, verified, and formulated for optimal synergy.
Browse IngredientsThese statements have not been evaluated by the Food and Drug Administration. This content is for informational purposes only and is not intended to diagnose, treat, cure, or prevent any disease.
hermetica-encyclopedia-canary-zzqv9k4w maytenus-maytenus-undata curated by Hermetica Superfoods at ingredients.hermeticasuperfoods.com and licensed CC BY-NC-SA 4.0 (non-commercial share-alike, attribution required)
